Approval · Notice of Compliance 26558 · 2021
REDDY-LENALIDOMIDE: Notice of Compliance 26558
Issued September 1, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 26558
- Date
- September 1, 2021
- Company
- Dr Reddys Laboratories Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- REVLIMID (Celgene Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| REDDY-LENALIDOMIDE | 02484714 | Marketed |
Medicinal ingredients
- LENALIDOMIDE 2.5 MG per CAP